Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications
David W. Dodick
Neurology
Research output
:
Contribution to journal
›
Review article
›
peer-review
62
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Calcitonin Gene-Related Peptide Receptors
100%
Migraine Disorders
67%
Monoclonal Antibodies
49%
Ligands
47%
Calcitonin Gene-Related Peptide
47%
Calcitonin Gene-Related Peptide Receptor Antagonists
21%
Tryptamines
18%
Subcutaneous Infusions
17%
Safety
15%
Subcutaneous Injections
13%
Intravenous Infusions
13%
Half-Life
11%
Pharmaceutical Preparations
11%
Therapeutics
10%
Pregnancy
8%
Population
5%